B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 720 KRW 1.51% Market Closed
Market Cap: 481.3B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Gross Profit
-â‚©11.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Gross Profit
â‚©1.2T
CAGR 3-Years
2%
CAGR 5-Years
19%
CAGR 10-Years
17%
SK Bioscience Co Ltd
KRX:302440
Gross Profit
â‚©142.2B
CAGR 3-Years
14%
CAGR 5-Years
23%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Gross Profit
â‚©278.5B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Gross Profit
â‚©211B
CAGR 3-Years
31%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Gross Profit
â‚©32.2B
CAGR 3-Years
N/A
CAGR 5-Years
82%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
481.7B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 394.57 KRW
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Gross Profit?
Gross Profit
-11.6B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Gross Profit amounts to -11.6B KRW.

Back to Top